Report says many R&D companies have based decisions on flawed data
R&D teams are confident in their evidence, yet report making decisions based on flawed or incomplete data, according to Elsevier’s Corporate R&D of the Future report.
The report is based on a global survey of more than 1,000 R&D leaders, managers and researchers at R&D-led corporations.
More than three quarters (76%) of respondents are confident in the quality of their data. Yet 63% of those who answered say their organisation has at some point made an important R&D decision using data or evidence later found to be inaccurate, incomplete or outdated.
About half (51%) say their organisation has had to make an important R&D decision before all the evidence was in.
The survey findings show artificial intelligence (AI) is moving into R&D decision-making, but expectations are running ahead of use: 81% expect AI to fundamentally transform how R&D decisions are made over the next five years, yet under half (47%) say it is used regularly in their organisation’s R&D function today.
Stuart Whayman, President, Corporate Markets at Elsevier, commented: “Confidence is not the same as accuracy. R&D teams are under pressure to decide faster, and often before all the evidence is in. Confidence keeps them moving, but it can’t make up for evidence that is incomplete, outdated or unreliable. AI will raise the stakes, because it will amplify whatever evidence it is given, good or bad. The advantage will go to the organisations that can bring their evidence together and trace and verify what sits behind their decisions.”
Survey findings show 78% have access to the third-party evidence they need, yet more than half (56%) of those still report at least one barrier. Across all respondents, the top barriers are scattered sources (42%), slow finding and synthesis (32%) and not knowing what evidence exists (30%).
R&D use of AI
Trusted evidence is seen as the AI advantage. 86% believe organisations that combine AI with trusted, high-quality evidence will outperform those that do not. Compliance, ease of use and accuracy are among the top factors that would increase willingness to use AI. 55% select AI that complies with laws and regulations, 54% AI that is easy to use and integrates with workflows, and 54% AI trained for factual accuracy and safety.
Compliance is a bigger draw in Europe. Among all respondents, 64% in Europe say they would be more willing to use AI if it complies with laws and regulations.
Scaling AI divides opinion. 48% say implementing AI at scale will be a significant challenge. The priorities selected most often for the next five years are building AI skills across the organisation (65%), turning data and evidence into actionable insights (62%) and tailoring AI to organisational knowledge and workflows (59%).
Scaling is seen as a challenge more in North America. Among all respondents, 56% in North America say implementing AI at scale will be a significant challenge, against 50% in Europe and 34% in APAC.
General-purpose tools lead for literature search. Of those answering, 48% use general-purpose AI tools such as ChatGPT or Copilot for literature search, against 23% who use specialist scientific AI tools. For data analysis and modeling, specialist tools are the most common choice.
